Mr. Billy Bruce Boughton is a pharmacist who is specialized in Oncology in Dallas, Texas. Patients can reach him at 3535 Worth St, Dallas or contact him on 214-370-1602. Active license number of Mr. Billy Bruce Boughton is 34661 for Oncology in Texas. Mr. Billy Bruce Boughton is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Mr. Billy Bruce Boughton speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mr. Billy Bruce Boughton
Specialization:
Oncology
Credentials:
RPH
Gender:
Male
Location:
3535 Worth St, Dallas, Texas, 75246-2006
Phone:
214-370-1602
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mr. Billy Bruce Boughton are as mentioned below.
NPI Number:
1518037985
NPI Enumeration Date:
09 Nov, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Billy Bruce Boughton are as mentioned below.
Specialization
License Number
State
Status
Oncology
34661
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2819 N Fitzhugh Ave, #2302 Dallas, Texas
Zip:
75204-3144
Phone Number:
214-728-4545
Fax Number:
--
Patients can reach Mr. Billy Bruce Boughton at 3535 Worth St, Dallas, Texas or can call on phone at 214-370-1602.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.